Atlas Trials

Median Effective Dose of Cisatracurium for the Prevention of Fasciculation Caused by the Injection of Succinylcholine

Clinical trial NCT05760976 · UNKNOWN

Trial details

NCT number
NCT05760976
Sponsor
Yangzhou University
Status
UNKNOWN
Phase
Not Applicable
Study type
INTERVENTIONAL
FasciculationSuccinylcholine
Start date
2023-02-01
Primary completion
2023-08-31
Enrollment
90

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.